National Centre for Clinical Research on Emerging Drugs (NCCRED)

What National Centre for Clinical Research on Emerging Drugs (NCCRED) does

The National Centre for Clinical Research on Emerging Drugs (NCCRED) is a small clinical research organization headquartered in Randwick, New South Wales, Australia, with a staff of 13. Its name indicates a specialization in clinical research concerning emerging drugs — a research domain typically associated with novel psychoactive substances, drug-checking services, or early-phase pharmacology — though the source data does not specify its precise research mandate, therapeutic focus areas, or institutional hosting arrangement. No products, services, partnerships, leadership team, funding arrangements, certifications, or operational history are documented in the available inputs.

The organization's web presence (nccred.org.au) returned only a loading and human-verification page at the time of data collection, yielding no substantive company content. There is no record of a parent company, subsidiaries, funding rounds, commercial revenue, or customer relationships. Ownership, incorporation jurisdiction, and company type are all unconfirmed. As a result, the business model, revenue mechanics, go-to-market approach, and customer segments cannot be characterized from the available evidence.

On the available signals, NCCRED appears to be an institutional research body — the "National Centre" designation is conventional language for publicly funded or university-hosted research units in Australia — rather than a commercially operating enterprise. Definitive conclusions about its mandate, funding base, operating model, or strategic positioning cannot be drawn without primary-source confirmation. This description is necessarily bounded by the data gap.

Name

National Centre for Clinical Research on Emerging Drugs (NCCRED)

Legal name

National Centre for Clinical Research on Emerging Drugs

Website

https://nccred.org.au

Company type

Private

Headcount range

11–50 employees

Short description

The National Centre for Clinical Research on Emerging Drugs (NCCRED) is a 13-person clinical research organization based in Randwick, New South Wales, Australia, whose name indicates a focus on clinical research into emerging drugs, though specific mandate, funding, and operational details are not documented in available source data.

Ownership category

akta.pro rank

Product category

Clinical Research Services

NAICS

Medical Laboratories (621511), Research and Development in the Physical, Engineering, and Life Sciences (54171)

SIC

Services-Medical Laboratories (8071)

akta.pro industry

PRIMARYHLAFAMAL

Clinical Research & Trial Central Laboratories

Healthcare & Life Sciences/Healthcare Providers & Systems/Clinical Laboratories

SECONDARYHLAJANAG

Chronic Disease & NCD Program Evaluation (e.g., diabetes/CVD/cancer)

Healthcare & Life Sciences/Public Health, Government & Regulators/Health Program Evaluation & Surveillance

SECONDARYEDAOAJAO

Clinical Research Support (CRC/CTA)

Education/Vocational, Technical & Trade Education/Healthcare Allied & Clinical Support Training

Keywords

• Clinical drug research
• Emerging substances trials
• Addiction research services
• Pharmacology clinical studies
• Harm reduction research

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Others

Core offering

The National Centre for Clinical Research on Emerging Drugs (NCCRED) is a clinical research organisation based in Randwick, New South Wales, Australia, focused on conducting clinical research on emerging drugs and novel psychoactive substances. It operates as a research centre addressing the public health impact of new and emerging drugs, supporting evidence-based responses to substance use.

Differentiator

Problem solved

Functional benefit

Products and services

• Clinical Research on Emerging Drugs

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Broad incumbents

• Black Dog Institute: Australian mental-health research institute running clinical trials and translational programs. Overlaps with NCCRED on clinical research into psychiatric and CNS-acting compounds.
• QIMR Berghofer Medical Research Institute: Large Australian medical research institute with translational and clinical-trial activity. Comparable as a research-centre operator running clinical studies relevant to pharmaceutical interventions.
• Baker Heart and Diabetes Institute: Australian medical research institute conducting clinical trials in cardiometabolic disease. Comparable as a translational clinical-research centre, though with a different therapeutic focus.
• Florey Institute of Neuroscience and Mental Health: Major Australian neuroscience and mental-health research institute. Comparable as a larger research body conducting clinical and translational studies relevant to CNS-acting emerging drugs.
• Brain and Mind Centre (University of Sydney): University of Sydney clinical-research centre focused on mental health and neuroscience. Comparable as a clinical-research operator running trials on psychotropic and addiction-related compounds.

Emerging players

• Orygen: Australian youth mental-health clinical-research organization. Comparable in running clinical trials of novel psychotropic and addiction-relevant interventions, though with a younger-population focus.

Direct peers

• Turning Point: Australian addiction-medicine research and treatment organization. Comparable as a clinical research centre working on substance use, addiction therapeutics, and emerging drugs.
• National Drug and Alcohol Research Centre (NDARC): UNSW-affiliated Australian research centre focused on drug and alcohol clinical research. Most directly comparable peer given shared Randwick/UNSW ecosystem and overlapping emerging-drug and addiction-medicine remit.

Regional players

• Centenary Institute: Sydney-based medical research institute with translational and clinical-research programs. Comparable in operating clinical and translational research relevant to emerging therapeutics, anchored in Australia.
• Hunter Medical Research Institute (HMRI): NSW-based clinical research institute. Comparable as an Australian clinical-research operator, though anchored in the Hunter region rather than Sydney.

Market position

Strengths3 records

Weaknesses3 records

Competitive moat2 records

Key risks4 records

Key highlights4 records

Customer concentration

• LinkedInlinkedin.com/company/nccred-aus

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about National Centre for Clinical Research on Emerging Drugs (NCCRED)